NIH Schedules Secret April Grant Review Sessions

2026-13479 — Government Owned Invention Available for License: Chimeric VLP Vaccines To Prevent HTLV-1 Infection

The National Cancer Institute has created a new vaccine to stop HTLV-1, a virus that can cause serious diseases like leukemia. Right now, no vaccine exists, so this invention could protect millions, especially in underserved areas. They’re looking for partners to help develop and license this promising vaccine, which could save lives and reduce healthcare costs in the near future.

2026-13480 — Government Owned Invention Available for License: A Conserved Viral Peptide for Use in Cancer Immunotherapy

The National Cancer Institute has created a special viral peptide that could help prevent and treat a serious liver cancer called HCC. This new discovery might lead to a vaccine or therapy that boosts the immune system to fight cancer better. Researchers and companies interested in developing this treatment can now license the technology, opening doors for faster progress and potential health benefits worldwide.

2026-13244 — The Federal Demonstration Partnership; Phase VIII Notice

The Federal Demonstration Partnership (FDP) is inviting colleges, universities, research groups, and hospitals that get federal research money to join its Phase VIII starting in 2027. This phase will keep testing new ways to make research funding and rules easier and faster. Applications are due by September 15, 2026, with the program running through the end of 2032.

2026-13337 — Center for Scientific Review; Notice of Closed Meetings

The Center for Scientific Review is holding several closed virtual meetings on July 24, 2026, to review and evaluate important grant applications related to cancer, imaging, eye diseases, and reproductive health. These meetings protect private info and trade secrets, so they’re not open to the public. Researchers and organizations applying for grants should note the dates as these reviews impact funding decisions.

2026-13311 — Center for Scientific Review; Notice of Closed Meetings

The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review grant applications and contract proposals. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants or contracts should watch these dates closely, as funding decisions could impact their projects and budgets.

2026-13204 — Proposed Collection; 30-Day Comment Request; NIH Information Collection Forms to Support the Genetic Testing Registry (OD)

The NIH wants your thoughts on updating forms that help track genetic tests in their registry. If you’re involved in genetic testing or research, these changes could affect how you share info. You’ve got until July 30, 2026, to send in your comments—no cost, just your voice to help make things smoother and smarter!

Previous: 2026-05315 — Center for Scientific Review; Amended Notice of Meeting

The NIH’s Clinical Management Study Section meeting on April 14-15, 2026, has a new lead reviewer—Dr. Heidi Friedman replaces Dr. Jessica Chambers. This change won’t affect the public since the meeting is closed, but it’s important for those involved in the review process. No changes to timing or funding were announced, just a leadership update to keep things running smoothly.

Next: 2026-05317 — Formations of, Acquisitions by, and Mergers of Bank Holding Companies

Some companies want to become bank holding companies or buy more shares in banks, which means they’ll have more control over those banks. If you’re interested, you can share your thoughts by April 17, 2026. These changes could affect how banks are owned and run, so keep an eye on the deadlines and details!